{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:03:26Z","timestamp":1788563006691,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010407","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"reference-count":113,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010407.pub2","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T14:05:55Z","timestamp":1470146755000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bioidentical hormones for women with vasomotor symptoms"],"prefix":"10.1002","volume":"2016","author":[{"given":"Ana Marcia IS","family":"Gaudard","sequence":"first","affiliation":[{"name":"School of Sciences of Health\/FEPECS; Management of educational evaluation; SMHN Quadra 3 conjunto A Bloco 1 Edif\u00edcio FEPECS Bras\u00edlia Brazil 70710-100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulani","family":"Silva de Souza","sequence":"additional","affiliation":[{"name":"School of Sciences of Health\/FEPECS; Management of educational evaluation; SMHN Quadra 3 conjunto A Bloco 1 Edif\u00edcio FEPECS Bras\u00edlia Brazil 70710-100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria ES","family":"Puga","sequence":"additional","affiliation":[{"name":"Centro de Estudos de Sa\u00fade Baseada em Evid\u00eancias e Avalia\u00e7\u00e3o Tecnol\u00f3gica em Sa\u00fade; Brazilian Cochrane Centre; Rua Borges Lagoa, 564 cj 63 S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Marjoribanks","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Rd Grafton Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina MK","family":"da Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R","family":"Torloni","sequence":"additional","affiliation":[{"name":"Centro de Estudos de Sa\u00fade Baseada em Evid\u00eancias e Avalia\u00e7\u00e3o Tecnol\u00f3gica em Sa\u00fade; Brazilian Cochrane Centre; Rua Borges Lagoa, 564 cj 63 S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"10.1002\/14651858.CD010407.pub2-BIB0001|cit1","first-page":"21","article-title":"Estrace vs Premarin for treatment of menopausal symptoms: dosage comparison study","volume":"9","author":"Archer","year":"1992","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD010407.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/01","article-title":"Percutaneous 17-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women","volume":"10","author":"Archer","year":"2003","journal-title":"The Journal of The North American Menopause Society"},{"issue":"6","key":"10.1002\/14651858.CD010407.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/gme.0b013e31823b8867","article-title":"Transdermal estradiol gel for the treatment of symptomatic postmenopausal women","volume":"19","author":"Archer","year":"2012","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0378-5122(97)00039-X","article-title":"Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch","volume":"27","author":"Bacchi-Modena","year":"1997","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1343\u201351","DOI":"10.1097\/AOG.0b013e318175d162","article-title":"Low-dose estradiol spray to treat vasomotor symptoms","volume":"111","author":"Buster","year":"2008","journal-title":"Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD010407.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0011-393X(99)80062-9","article-title":"Low-dose 17-beta estradiol matrix transdermal system in the treatment of moderate-to-severe hot flushes in postmenopausal women","volume":"60","author":"Cohen","year":"1999","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0007|cit7","first-page":"293","article-title":"Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches","volume":"50","author":"Aloysio","year":"2000","journal-title":"Azneimittelforschung"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5122(99)00085-7","article-title":"Efficacy and tolerability of a new estradiol delivering matrix patch (Estraderm MX) in postmenopausal women","volume":"34","author":"Vrijer","year":"2000","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/13697139909025560","article-title":"Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms","volume":"2","author":"Good","year":"1999","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0010|cit10","first-page":"126","article-title":"Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo","volume":"40","author":"Gordon","year":"1995","journal-title":"International Journal of Fertility and Menopausal Studies"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"419\u201326","DOI":"10.1080\/13697130902748967","article-title":"Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial","volume":"12","author":"Haines","year":"2009","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"319\u201328","DOI":"10.1080\/13697130802657888","article-title":"Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial","volume":"12","author":"Honjo","year":"2009","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2005.04.003","article-title":"Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study","volume":"53","author":"Nielsen","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00042192-200007050-00005","article-title":"Initial 17beta-estradiol dose for treating vasomotor symptoms","volume":"7","author":"Notelovitz","year":"2000","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00042192-200007050-00005","article-title":"Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol","volume":"7","author":"Notelovitz","year":"2000","journal-title":"Menopause"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0016|cit16","first-page":"114","article-title":"Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study","volume":"22","author":"Rovati","year":"2002","journal-title":"Menopause: The Journal of The North American Menopause Society"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.gme.0000174096.56652.4f","article-title":"Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms","volume":"13","author":"Simon","year":"2006","journal-title":"Menopause: The Journal of The North American Menopause Society"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.AOG.0000254160.62588.41","article-title":"Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial","volume":"109","author":"Simon","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0029-7844(96)00272-4","article-title":"Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms","volume":"88","author":"Speroff","year":"1996","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0029-7844(96)00272-4","article-title":"Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms","volume":"88","author":"Speroff","year":"1996","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9378(99)70438-2","article-title":"Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients","volume":"181","author":"Utian","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5122(99)00099-7","article-title":"Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints","volume":"34","author":"Holst","year":"2000","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9378(12)90828-5","article-title":"Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study","volume":"168","author":"Wiklund","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0024|cit24","first-page":"64","article-title":"A comparison of transdermal and oral HRT for menopausal symptom control","volume":"51","author":"Akhila","year":"2006","journal-title":"International Journal of Fertility and Women's Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010407.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.GME.0000094541.07420.7C","article-title":"Estrogen no matter how delivered relieves postmenopausal vasomotor symptoms","volume":"10","author":"Bachmann","year":"2003","journal-title":"Menopause"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"771\u20139","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17-estradiol dose for relief of hot flushes in postmenopausal women","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0027|cit27","first-page":"9","article-title":"What's the lowest effective estrogen dose for hot flushes?","volume":"57","author":"Bachmann","year":"2008","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0028|cit28","first-page":"302","article-title":"Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms","volume":"7","author":"Ben-Chetrit","year":"2005","journal-title":"Israeli Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0029|cit29","first-page":"171","article-title":"Low and ultra low-dose estrogen therapy for climacteric symptom control - preliminary report","volume":"51","author":"Carranza-Lira","year":"2006","journal-title":"International Journal of Fertility and Women's Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/09513590903159698","article-title":"The role of intranasal estradiol spray in the management of moderate to severe vasomotor symptoms in menopausal women","volume":"26","author":"Castelo-Branco","year":"2010","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5122(96)01050-X","article-title":"A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms","volume":"25","author":"Chung","year":"1996","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0032|cit32","first-page":"153","article-title":"Bioidentical hormones: an evidence-based review for primary care providers","volume":"111","author":"Conaway","year":"2011","journal-title":"Journal of the American Osteopathic Association"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0033|cit33","first-page":"1","article-title":"Treatment of menopausal symptoms with three low-dose continuous sequential 17\u03b2-estradiol\/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology","volume":"10","author":"Cort\u00e9s-Bonilla","year":"2015","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-5122(91)90093-6","article-title":"Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women","volume":"13","author":"Darj","year":"1991","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.gme.0000192439.82491.24","article-title":"Effects of ultra low-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years","volume":"13","author":"Diem","year":"2006","journal-title":"Menopause"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2007.02.025","article-title":"Rationale for use of lower estrogen doses for postmenopausal hormone therapy","volume":"57","author":"Ettinger","year":"2007","journal-title":"Maturitas"},{"issue":"7","key":"10.1002\/14651858.CD010407.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4065\/mcp.2010.0714","article-title":"Bioidentical hormone therapy","volume":"86","author":"Files","year":"2011","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/IJGM.S16139","article-title":"Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: a pilot study","volume":"4","author":"Formby","year":"2011","journal-title":"International Journal of General Medicine"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1016\/S0002-9149(01)02218-4","article-title":"Vasomotor and vascular effects of hormone replacement therapy","volume":"90","author":"Ganz","year":"2002","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.maturitas.2003.12.004","article-title":"A short study in the treatment of hot flashes with buccal administration of 17- estradiol","volume":"49","author":"Gass","year":"2004","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/gme.0b013e31817d5372","article-title":"Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women","volume":"16","author":"Hedrick","year":"2009","journal-title":"The Journal of The North American Menopause Society"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/jwh.2009.1915","article-title":"Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center","volume":"20","author":"Iftikhar","year":"2011","journal-title":"Journal of Women\u2019s Health"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0378-5122(87)90003-X","article-title":"Climacteric symptoms after oral and percutaneous hormone replacement therapy","volume":"9","author":"Jensen","year":"1987","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"173\u201380","DOI":"10.1016\/j.atherosclerosis.2004.01.021","article-title":"Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial","volume":"174","author":"Lacut","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(03)00187-7","article-title":"Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy","volume":"48","author":"Lindh-\u00c5strand","year":"2003","journal-title":"Maturitas"},{"issue":"6","key":"10.1002\/14651858.CD010407.pub2-BIB0046|cit46","first-page":"906","article-title":"Randomized comparison of intranasal and transdermal estradiol","volume":"96","author":"Lopes","year":"2000","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"117\u201325","DOI":"10.1016\/S0378-5122(97)00067-4","article-title":"Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern","volume":"28","author":"L\u00fcbbert","year":"1997","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1744-1609.2009.00133.x","article-title":"Evidence-based review of therapies at the menopause","volume":"7","author":"MacLennan","year":"2009","journal-title":"International Journal of Evidence Based Healthcare"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0378-5122(91)90280-4","article-title":"Progestogens: therapeutic and adverse effects in early post-menopausal women","volume":"13","author":"Marslew","year":"1991","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-5122(94)90075-2","article-title":"Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use","volume":"19","author":"Marslew","year":"1994","journal-title":"Maturitas"},{"issue":"12","key":"10.1002\/14651858.CD010407.pub2-BIB0051|cit51","first-page":"4644\u201349","article-title":"Preserved forearm endothelial responses with acute exposure to progesterone: a randomized cross-over trial of 17-b estradiol, progesterone, and 17-b estradiol with progesterone in healthy menopausal women","volume":"85","author":"Mather","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.maturitas.2015.02.266","article-title":"17(beta)-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review","volume":"81","author":"Mirkin","year":"2015","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"581\u201389","DOI":"10.3109\/13697137.2011.570388","article-title":"Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms","volume":"14","author":"Mizunuma","year":"2011","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0022-3859.33966","article-title":"A prospective randomized comparative study of the effects of intranasal and transdermal 17\u00df estradiol on postmenopausal symptoms and vaginal cytology","volume":"53","author":"Odaba\u015fi","year":"2007","journal-title":"Journal of Postgraduate Medicine"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13697130701298107","article-title":"Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief","volume":"10","author":"Panay","year":"2007","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5122(01)00170-0","article-title":"Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause","volume":"40","author":"P\u00e9lissier","year":"2001","journal-title":"Maturitas"},{"issue":"7","key":"10.1002\/14651858.CD010407.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0735-1097(00)01007-X","article-title":"Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women","volume":"36","author":"Rosano","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD010407.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1099\u20131115","DOI":"10.1016\/S0149-2918(01)80094-1","article-title":"Quality of life and costs associated with micronized progesterone and medroxyprogesterone acetate in hormone replacement therapy for nonhysterectomized, postmenopausal women","volume":"23","author":"Ryan","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0059|cit59","first-page":"525\u201333","article-title":"Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy","volume":"31","author":"Serfaty","year":"2003","journal-title":"Gyn\u00e9cologie Obst\u00e9trique and Fertilit\u00e9"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"77\u201380","DOI":"10.1016\/j.maturitas.2007.02.015","article-title":"Routes of delivery for progesterone and progestins","volume":"57","author":"Sitruk-Ware","year":"2007","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.maturitas.2012.11.007","article-title":"Beliefs about bioidentical hormone therapy: a cross-sectional survey of pharmacists","volume":"74","author":"Siyam","year":"2013","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5122(00)00141-9","article-title":"Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints","volume":"36","author":"Skarsgard","year":"2000","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.maturitas.2006.06.004","article-title":"The effect of tibolone versus 17-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study","volume":"56","author":"Somunkiran","year":"2007","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"202\u201310","DOI":"10.3122\/jabfm.2011.02.100194","article-title":"Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians","volume":"24","author":"Sood","year":"2011","journal-title":"Journal of the American Board of Family Medicine"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"375\u2013 82","DOI":"10.1016\/j.maturitas.2013.01.010","article-title":"Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial","volume":"74","author":"Sood","year":"2013","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0140-6736(98)06196-0","article-title":"Efficacy and acceptability of intranasal 17 -oestradiol for menopausal symptoms: randomised dose-response study","volume":"353","author":"Studd","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5122(96)01100-0","article-title":"Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy","volume":"26","author":"Suvanto-Luukkonen","year":"1997","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5122(93)90008-6","article-title":"Effects and acceptability of a new 17B-oestradiol releasing vaginal ring in the treatment of postmenopausal complaints","volume":"17","author":"Vartiainen","year":"1993","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/GME.0b013e31826ce3ed.","article-title":"The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial","volume":"20","author":"Veerus","year":"2013","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1345\/aph.1R362","article-title":"Bioidentical progesterone cream for menopause-related vasomotor symptoms: is it effective?","volume":"47","author":"Whelan","year":"2013","journal-title":"The Annals of Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psyneuen.2004.05.005","article-title":"Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women","volume":"30","author":"Wihlb\u00e4ck","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0378-5122(94)90127-9","article-title":"Early effects of continuous low-dosage dl-norgestrel administered alone or with estrogen","volume":"18","author":"Wolfe","year":"1994","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/humrep\/deh011","article-title":"Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause","volume":"19","author":"Yesildaglar","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00042192-200111000-00009","article-title":"Women\u2019s beliefs about \u201cnatural\u201d hormones and natural hormone replacement therapy","volume":"8","author":"Adams","year":"2001","journal-title":"Menopause"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1081\/CBI-120005394","article-title":"Regulation of the 24h body temperature rhythm of women in luteal phase: role of gonadal steroids and prostaglandins","volume":"19","author":"Cagnacci","year":"2002","journal-title":"Chronobiology International Journal"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/gme.0000000000000258","article-title":"Low-dose transdermal estradiol for vasomotor symptoms: a systematic review","volume":"22","author":"Corbelli","year":"2014","journal-title":"Menopause: The Journal of The North American Menopause Society"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0077|cit77","first-page":"79","article-title":"A decade of experience with transdermal estrogen replacement therapy: overview of key pharmacologic and clinical findings","volume":"38","author":"Corson","year":"1993","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0078|cit78","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0079|cit79","first-page":"414","article-title":"Natural isomolecular hormone replacement: an evidence-based medicine approach","volume":"4","author":"Drisko","year":"2000","journal-title":"International Journal of Pharmaceutical Compounding"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0080|cit80","unstructured":"European Medicines Agency Guideline on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women ema.europa.eu\/ema\/ Accessed September 2012"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0081|cit81","unstructured":"Endocrine Society Bioidentical hormones: position statement endo-society.org\/advocacy\/policy\/upload\/BH_position_Statement_final_10_25_06_w_Header.pdf"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0082|cit82","unstructured":"US Department of Health and Human Services Guidance for industry: estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms\u2014recommendations for clinical evaluation fda.gov\/cder\/guidance\/index.htm January 2003"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajhb.1077","article-title":"Physiology of hot \ufb02ashes","volume":"13","author":"Freedman","year":"2001","journal-title":"American Journal of Human Biology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.fertnstert.2005.08.026","article-title":"Cortical activation during menopausal hot flashes","volume":"85","author":"Freedman","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD010407.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0086|cit86","unstructured":"McMaster University (developed by Evidence Prime, Inc). Available from gradepro.org GRADEpro Guideline Development Tool 2015"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2011-3362","article-title":"Executive summary of the Stages of Reproductive Aging Workshop D10: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"Harlow","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"13","key":"10.1002\/14651858.CD010407.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.291.13.1610","article-title":"Commonly used types of postmenopausal estrogen for treatment of hot flashes","volume":"219","author":"Heidi","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0091|cit91","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0092|cit92","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(96)82006-8","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08870449208404294","article-title":"Women's Health Questionnaire: a measure of mid-aged women's perceptions of their emotional and physical health","volume":"7","author":"Hunter","year":"1992","journal-title":"Psychology and Health"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0095|cit95","first-page":"197","article-title":"Women and menopause: beliefs, attitudes, and behaviours","volume":"5","author":"Kaufert","year":"1998","journal-title":"Menopause"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0096|cit96","first-page":"193","article-title":"Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies","volume":"6","author":"Kopper","year":"2009","journal-title":"Journal of Drug Design Development and Therapy"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0306-4565(92)90018-B","article-title":"Modulation of menopausal hot flashes by ambient temperature","volume":"17","author":"Kronnenberg","year":"1992","journal-title":"Journal of Thermal Biology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"CD001395","DOI":"10.1002\/14651858","article-title":"Phytoestrogens for menopausal vasomotor symptoms","volume":"12","author":"Lethaby","year":"2013","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD010407.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"Hormone therapy position statement of The North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"The Journal of The North American Menopause Society"},{"issue":"17","key":"10.1002\/14651858.CD010407.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00198-003-1535-8","article-title":"Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study","volume":"15","author":"Nielsen","year":"2004","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0102|cit102","unstructured":"The Nordic Cochrane Centre, Cochrane Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin for healthy postmenopausal women","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD010407.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/AOG.0b013e31827a08c8","article-title":"Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy","volume":"121","author":"Rossouw","year":"2013","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0105|cit105","first-page":"1271","article-title":"Alternative treatments for menopausal symptoms: qualitative study of women\u2019s experiences","volume":"44","author":"Seidl","year":"1998","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/gme.0b013e31803867a","article-title":"A randomised, open-label, crossover study comparing the effects of oral versus transdermal estrogens therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women","volume":"14","author":"Shifren","year":"2007","journal-title":"Menopause"},{"issue":"4","key":"10.1002\/14651858.CD010407.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/AOG.0b013e3181d41191","article-title":"Role of hormone therapy in the management of menopause","volume":"115","author":"Shifren","year":"2010","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0108|cit108","article-title":"Clinical Gynecologic Endocrinology and Infertility","volume-title":"Clinical Gynecologic Endocrinology and Infertility","author":"Speroff","year":"2011"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-73-2-275","article-title":"Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure","volume":"73","author":"Steingold","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/13697137.2011.570590","article-title":"Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health","volume":"14","author":"Sturdee","year":"2011","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0111|cit111","first-page":"340","article-title":"Objective techniques for the assessment of menopausal hot flushes","volume":"57","author":"Tartaryn","year":"1981","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010407.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-95-4-468","article-title":"Flushing reactions: consequences and mechanisms","volume":"95","author":"Wilkin","year":"1981","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010407.pub2-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010407","article-title":"Bioidentical hormones for women with hot flushes","author":"Gaudard","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010407.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T04:18:57Z","timestamp":1717647537000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010407.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":113,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010407.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,1]]}}}